Literature DB >> 31964580

Exercise and Arrhythmogenic Right Ventricular Cardiomyopathy.

David Prior1, Andre La Gerche2.   

Abstract

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a group of cardiomyopathies associated with ventricular arrhythmias predominantly arising from the right ventricle, sudden cardiac death and right ventricular failure, caused largely due to inherited mutations in proteins of the desmosomal complex. Whilst long recognised as a cause of sudden cardiac death (SCD) during exercise, it has recently been recognised that intense and prolonged exercise can worsen the disease resulting in earlier and more severe phenotypic expression. Changes in cardiac structure and function as a result of exercise training also pose challenges with diagnosis as enlargement of the right ventricle is commonly seen in endurance athletes. Advice regarding restriction of exercise is an important part of patient management, not only of those with established disease, but also in individuals known to carry gene mutations associated with development of ARVC.
Copyright © 2019 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ARVC; Arrhythmogenic; Cardiomyopathy; Exercise; Genetics

Mesh:

Year:  2019        PMID: 31964580     DOI: 10.1016/j.hlc.2019.12.007

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  7 in total

1.  Normative values of non-invasively assessed RV function and pulmonary circulation coupling for pre-participation screening derived from 497 male elite athletes.

Authors:  Pascal Bauer; Khodr Tello; Lutz Kraushaar; Oliver Dörr; Stanislav Keranov; Faeq Husain-Syed; Holger Nef; Christian W Hamm; Astrid Most
Journal:  Clin Res Cardiol       Date:  2022-09-14       Impact factor: 6.138

2.  Facts and Gaps in Exercise Influence on Arrhythmogenic Cardiomyopathy: New Insights From a Meta-Analysis Approach.

Authors:  Julia Martínez-Solé; María Sabater-Molina; Aitana Braza-Boïls; Juan J Santos-Mateo; Pilar Molina; Luis Martínez-Dolz; Juan R Gimeno; Esther Zorio
Journal:  Front Cardiovasc Med       Date:  2021-10-18

3.  Cardiac desmosomal reserve: another piece of the exercise-induced arrhythmogenic cardiomyopathy puzzle?

Authors:  Kristina H Haugaa; Christine Rootwelt-Norberg
Journal:  Eur Heart J       Date:  2022-03-21       Impact factor: 29.983

4.  Arrhythmogenic right ventricular cardiomyopathy characterized by recurrent syncope during exercise: A case report.

Authors:  Hao-Yu Wu; Yi-Wei Cao; Tian-Jiao Gao; Jian-Li Fu; Lei Liang
Journal:  World J Clin Cases       Date:  2021-06-06       Impact factor: 1.337

5.  Extracellular vesicles from immortalized cardiosphere-derived cells attenuate arrhythmogenic cardiomyopathy in desmoglein-2 mutant mice.

Authors:  Yen-Nien Lin; Thassio Mesquita; Lizbeth Sanchez; Yin-Huei Chen; Weixin Liu; Chang Li; Russell Rogers; Yizhou Wang; Xinling Li; Di Wu; Rui Zhang; Ahmed Ibrahim; Eduardo Marbán; Eugenio Cingolani
Journal:  Eur Heart J       Date:  2021-09-14       Impact factor: 35.855

Review 6.  Mechanotransduction and Adrenergic Stimulation in Arrhythmogenic Cardiomyopathy: An Overview of in vitro and in vivo Models.

Authors:  Giorgia Beffagna; Elena Sommariva; Milena Bellin
Journal:  Front Physiol       Date:  2020-11-12       Impact factor: 4.755

Review 7.  The Female Athlete's Heart: Overview and Management of Cardiovascular Diseases.

Authors:  Silvia Castelletti; Sabiha Gati
Journal:  Eur Cardiol       Date:  2021-12-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.